Nicholas Conrad Smith - CHIEF FINANCIAL OFFICER at Alto Neuroscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ANRO on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas Conrad Smith since 12/26/2023

Holdings reported by Nicholas Conrad Smith for Alto Neuroscience, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (Right to Buy) 90K Mar 1, 2024 Direct Common Stock
Common Stock 26.9K Mar 28, 2024 Direct

Transactions reported by Nicholas Conrad Smith for Alto Neuroscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.